GIT1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemGIT1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-35477-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene NameGIT ArfGAP 1
NCBI Gene Aliasesp95-APP1
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) GIT1 protects against breast cancer growth through negative regulation of NotchNature communicationsMarch 22, 2022Zhang S, Miyakawa A, Wickström M, Dyberg C, Louhivuori L, Varas-Godoy M, Kemppainen K, Kanatani S, Kaczynska D, Ellström ID, et al.GIT1 siRNA (Cat. HSS178932, Invitrogen), control siRNA (Cat. 45–2001, Invitrogen), GIT1 shRNA (Cat. sc-35477-SH, Santa Cruz Biotechnology), and control shRNA (Cat. sc-108066, Santa Cruz Biotechnology) was performed

(2) miR-195 inhibits the proliferation and migration of chondrocytes by targeting GIT1Molecular medicine reportsJanuary 1, 2017Gu YL, Rong XX, Wen LT, Zhu GX, Qian MQ.

(3) miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiationExperimental and therapeutic medicineDecember 1, 2016Tu XM, Gu YL, Ren GQ.

(4) Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cellsThe American journal of pathologyApril 1, 2015Peng H, Li TW, Yang H, Moyer MP, Mato JM, Lu SC.

(5) GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinomaOncoTargets and therapyJanuary 1, 2015Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X.

Be the First to Write a Review!